Neurelis, INC.

Biopharmaceutical company specializing in treatments for neurological conditions.

Based in CA

🤖

AI Overview

With $80K in lobbying spend across 6 quarterly filings, Neurelis, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2024 to 2025.

$80K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2024	$30K
2025	$50K

Issues Lobbied

Health Issues Medicare/Medicaid

Lobbying Firms

Arnold & Porter Kaye Scholer LLP

Lobbyists

Sonja Nesbit Bobby Mcmillin Eugenia Pierson

Government Agencies Targeted

These are the government entities that Neurelis, INC. disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid

Policy issues related to federal regulation of the healthcare industry.

Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Retaining Access and Restoring Exclusivity (RARE) Act (H.R. 7383 / S. 1214, 118th Congress).

Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).

Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Give Kids a Chance Act (119th, H.R. 1262 / S. 932) and Retaining Access and Restoring Exclusivit